Color Doppler ultrasound in the preoperative assessment of adnexal masses

References

• Meire H B, Farrant P, Guha T. Distinction of benign from malignant ovarian cysts by ultrasound. Br J Obstet Gynaecol 1978; 85: 893–9
   PubMedGoogle Scholar
• Grauberg S, Wikland M, Janson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol 1989; 35: 139–44
   Google Scholar
• Sassone M, Timor-Tritsch I E, Artner A, Westhoff C, Warren W B. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78: 70–6
   PubMed Web of Science ®Google Scholar
• Hata T, Hata K, Senoh D, et al. Doppler ultrasound assessment of tumor vascularity in gynecologic disorders. J Ultrasound Med 1989; 8: 309–14
   PubMed Web of Science ®Google Scholar
• Kurjak A, Zalud I, Jurcovic Z, Miljan M. Transvaginal color Doppler for the assessment of pelvic circulation. Acta Obstet Gynecol Stand 1989; 68: 131–5
   PubMed Web of Science ®Google Scholar
• Boume T, Campbell S, Steer C, Whitehead M, Collins W P. Transvaginal color flow imaging: a possible new screening for ovarian cancer. Br Med J 1989; 299: 1367–70
   Google Scholar
• Kurjak A, Zalud I, Alfirevic Z. Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 1991; 10: 295–7
   PubMed Web of Science ®Google Scholar
• Fleischer A C, Rodgers W H, Rao B K, et al. Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med 1991; 10: 563–8
   PubMed Web of Science ®Google Scholar
• Kawai M, Kano T, Kikkawa F, Maeda O, Oguchi H, Tomoda Y. Transvaginal Doppler ultrasound with color flow imaging in the diagnosis of ovarian cancer. Obstet Gynecol 1992; 79: 163–7
   PubMed Web of Science ®Google Scholar
• Weiner Z, Thaler I, Beck D, Rottem S, Deutsch M, Brandes J. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol 1992; 79: 159–62
   PubMed Web of Science ®Google Scholar
• Blood C, Zetter B. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89–118
   PubMed Web of Science ®Google Scholar
• Fleischer A C, Rogers W H, Rao B K, Keppler D M, Jones H W. Transvaginal color Doppler sonography of ovarian masses with pathological correlation. Ultrasound Obstet Gynecol 1991; 1: 275–8
   Google Scholar
• Fleischer A C, Rodgers W H, Kepple D M, Williams L L, Jones H W. Color doppler sonography of ovarian masses: a multiparameter analysis. J Ultrasound Med 1993; 12: 41–5
   Google Scholar
• Tekay A, Jouppila P. Validity of pulsatility and resistance indices in classification of adnexal tumors with transvaginal color Doppler ultrasound. Ultrasound Obstet Gynecol 1992; 2: 338–44
   PubMed Web of Science ®Google Scholar
• Kurjak A, Predanic M, Kupesic-Urek S, Jukic S. Transvaginal color and pulsed Doppler assessment of adnexal tumor vascularity. Gynecol Oncol 1993; 50: 3–9
   PubMed Web of Science ®Google Scholar
• Hata K, Hata T, Manabe A, Kitao M. Ovarian tumors or low malignancy potential: transvaginal Doppler ultrasound features. Gynecol Oncol 1992; 45: 259–64
   Google Scholar
• Herrmann U J, Jr, Locher G W, Goldhirsch A. Sonographic patterns of ovarian tumors: prediction of malignancy. Obstet Gynecol 1987; 69: 777–81
   PubMed Web of Science ®Google Scholar
• Granberg S, Norsrom A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 1990; 37: 224–9
   PubMed Web of Science ®Google Scholar
• Madjar H, Sauerbrei W, Münch A, Schillinger H. Continuous-wave and pulsed Doppler studies of the breast: clinical results and effect of transducer frequency. Ultrasound Obstet Gynecol 1991; 1: 275–8
   Google Scholar
• Matta W H. M, Stabile I, Shaw R W, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil Steril 1988; 49(6)1083–5
   Web of Science ®Google Scholar
• Malkasian G D, Knapp R C, Lavin P T, et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988; 159: 341–6
   PubMed Web of Science ®Google Scholar
• Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzin-Skas J G. A risk of malignancy index incorporating CA 125, ultrasound and menopusal status for the accurate preoperative diagnosis of ovarian cancer. Brit J Obstet Gynecol 1990; 97: 922–9
   PubMedGoogle Scholar
• Van Nagell J R. Ovarian cancer (Editorial). Gynecol Oncol 1991; 43: 89–91
   PubMedGoogle Scholar
• Grover S, Quinn M A, Weideman P, Koh H. Factors influencing serum CA 125 levels in normal women. Obstet Gynecol 1992; 79: 511–4
   Google Scholar